Health
Coronavirus (COVID-19) Update: FDA Authorizes First Tests that Estimate a Patient’s Antibodies from Past SARS-CoV-2 Infection – FDA.gov
Today, FDA authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual’s blood
For Immediate Release:
July 31, 2020
Today, the U.S. Food and Drug Administration authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individuals blood. Both tests from Siemens, the ADVIA Centaur COV2G and Attelica COV2G, are what are known as semi-quantitative tests, meaning that they do not display a precise measurement, but estimate the quantity of a patients antibodies produced against infection with the virus that causes COVID-1…
-
Business15 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business17 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business14 hours agoHere’s what analysts expect for the BHP share price in the coming year